GBP 100 discount for all SBA members. Please ask the organizer before registering to this congress.

The 2020 event will assess innovations in device engineering and components, enhancement of human factors, and optimizing packaging and containment.

With the rapid expansion of the PFS market, the regulatory environment is more importance than ever. This year’s program will look at the EU MDR, Article 117 as well as insights into the MDR post-market surveillance requirements; providing a holistic review of the pre-filled syringes industry.

This two-day agenda offers you peer-to-peer networking with global product managers, senior pre-filled syringes engineers, device testing managers, heads of late-stage pre-filled syringes development, heads of medical affairs, senior directors – combination products & medical devices, global regulatory affairs, quality assurance manager combination products , senior pharmaceutical assessors and many more.


  • Learn about the technological innovations that are revolutionizing the injectable drug delivery space through novel device design
  • Debate how can we prepare for the regulatory impact of Brexit and the EU MDR on devices
  • Hear industry experts uncovering the latest advancements optimizing drug biologics to improve PFS delivery
  • Assess industry case studies exploring how to overcome challenges of extractables and leachables

Plus, pre-conference workshop day on January 14 in London:

Workshop A: A Roadmap to regulation quality management systems and technical standards

Workshop B: Testing requirements of pre-filled syringes led by Horst Koller, CEO, HK Packaging Consulting GmbH

Workshop C: Extractables and leachables: Considerations for PFS Platforms

Contact Form